BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17194636)

  • 1. Association between serum free IGF-I and IGFBP-3 levels in type-I diabetes patients affected with associated autoimmune diseases or diabetic complications.
    Capoluongo E; Pitocco D; Santonocito C; Concolino P; Santini SA; Manto A; Lulli P; Ghirlanda G; Zuppi C; Ameglio F
    Eur Cytokine Netw; 2006 Sep; 17(3):167-74. PubMed ID: 17194636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverse correlation between serum free IGF-I and IGFBP-3 levels and blood pressure in patients affected with type 1 diabetes.
    Capoluongo E; Pitocco D; Lulli P; Minucci A; Santonocito C; Manto A; Di Stasio E; Zaccardi F; Zuppi C; Ghirlanda G; Ameglio F
    Cytokine; 2006 Jun; 34(5-6):303-11. PubMed ID: 16887362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid hormone modulates insulin-like growth factor-I(IGF-I) and IGF-binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid diseases.
    Inukai T; Takanashi K; Takebayashi K; Fujiwara Y; Tayama K; Takemura Y
    Horm Metab Res; 1999 Oct; 31(10):576-9. PubMed ID: 10596968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
    Akturk M; Arslan M; Altinova A; Ozdemir A; Ersoy R; Yetkin I; Ayvali E; Gonen S; Toruner F
    Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study.
    Simó R; Hernández C; Segura RM; García-Arumí J; Sararols L; Burgos R; Cantón A; Mesa J
    Clin Sci (Lond); 2003 Mar; 104(3):223-30. PubMed ID: 12605576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).
    Harris TG; Strickler HD; Yu H; Pollak MN; Monrad ES; Travin MI; Xue X; Rohan TE; Kaplan RC
    Growth Horm IGF Res; 2006 Apr; 16(2):86-92. PubMed ID: 16530441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
    Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
    Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins.
    Feldmann B; Jehle PM; Mohan S; Lang GE; Lang GK; Brueckel J; Boehm BO
    Growth Horm IGF Res; 2000 Feb; 10(1):53-9. PubMed ID: 10753593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of growth factor levels in adolescents with type 1 diabetes mellitus and the beginning of diabetic microangiopathy].
    Peczyńska J; Urban M; Urban B; Głowińska B; Florys B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):41-8. PubMed ID: 15355738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in IGF-I levels and its binding proteins in diabetes mellitus and obesity].
    Krsek M; Skrha J; Sucharda P; Justová V; Lacinová Z
    Cas Lek Cesk; 2003; 142(4):216-9. PubMed ID: 12841123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of free insulin-like growth factor-I in human serum: comparison of ultrafiltration and direct immunoradiometric assay.
    Frystyk J; Ivarsen P; Støving RK; Dall R; Bek T; Hagen C; Ørskov H
    Growth Horm IGF Res; 2001 Apr; 11(2):117-27. PubMed ID: 11472078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes.
    Hedman CA; Frystyk J; Fridell K; Jönsson A; Flyvbjerg A; Lindström T; Arnqvist HJ
    Growth Horm IGF Res; 2005 Aug; 15(4):304-10. PubMed ID: 16054412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The insulin-like growth factor system and Type 1 diabetic retinopathy during pregnancy.
    Loukovaara S; Immonen IJ; Koistinen R; Rutanen EM; Hiilesmaa V; Loukovaara M; Kaaja RJ
    J Diabetes Complications; 2005; 19(5):297-304. PubMed ID: 16112506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
    Janssen JA; Jacobs ML; Derkx FH; Weber RF; van der Lely AJ; Lamberts SW
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF).
    Brausewetter F; Jehle PM; Jung MF; Boehm BO; Brueckel J; Hombach V; Osterhues HH
    Horm Metab Res; 2001 Dec; 33(12):713-20. PubMed ID: 11753756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J; Urban M; Głowińska B; Urban B
    Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
    Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis.
    Hamaguchi Y; Fujimoto M; Matsushita T; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2008 Dec; 35(12):2363-71. PubMed ID: 19004037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in adults with inflammatory bowel disease.
    Katsanos KH; Tsatsoulis A; Christodoulou D; Challa A; Katsaraki A; Tsianos EV
    Growth Horm IGF Res; 2001 Dec; 11(6):364-7. PubMed ID: 11914023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index, free insulin-like growth factor I, and physical function among older adults: results from the ilSIRENTE study.
    Onder G; Liperoti R; Russo A; Soldato M; Capoluongo E; Volpato S; Cesari M; Ameglio F; Bernabei R; Landi F
    Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E829-34. PubMed ID: 16684849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.